ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors

Overview of attention for article published in BMC Medicine, May 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)

Mentioned by

twitter: 3 X users

reddit: 1 Redditor

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 17 Mendeley

Summary X Reddit Dimensions citations

So far, Altmetric has seen 1 Reddit thread.

ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors | BMC Medicine

User montaukwhaler, in the non small cell lung cancer subreddit, 12 May 2022

This page shows the most recent Reddit threads that mention this research output.

Click here to find out how to access more activity.